Australia: Docetaxel case


[Bloomberg]

The interlocutory petition for restraining generic launch of Docetaxel in Australia is denied by federal judge.

Docetaxel product per se is protected by patent no AU591309 (expiry: Feb 06, 2011) and composition is protected by patent no AU666859 (expiry: July 2012). The generic companies (Hospira & interpharma) intends to launch generic version after the product patent expiry ie after Feb 06, 2011.

Injunction against generic companies is not granted

[Order]

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s